The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...

The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for those who pay cash for the ...

The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...

Novo Nordisk maintains strong growth prospects, driven by obesity treatment market expansion. See why NVO stock is a strong ...

The changes come days after the Trump administration announced agreements with Novo Nordisk and Eli Lilly intended to widen ...

Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.

The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for ...

For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re ...

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger ...